Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer Cells

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• Prohibitin (PHB) is a known tumor suppressor gene involved in various cellular processes.
• PHB's role in prostate cancer, particularly its interaction with the androgen receptor (AR) and cell cycle regulators like E2F, is complex and warrants further investigation.
• Dysregulation of PHB is implicated in cancer progression, but its specific molecular mechanisms in prostate cancer metastasis are not fully elucidated.

Purpose of the Study:

• To investigate the molecular mechanisms by which Prohibitin (PHB) influences prostate cancer cell behavior, including proliferation, migration, and invasion.
• To elucidate the interplay between PHB, androgen receptor (AR), E2F family members, and WNT signaling in prostate cancer.
• To determine the correlation between PHB expression levels and clinical outcomes in metastatic prostate cancer.

Main Methods:

• Utilized in vitro assays including cell cycle analysis (G1/S-phase arrest), gene silencing (siRNA), and ectopic gene expression (cDNA) in LNCaP prostate cancer cells.
• Investigated protein-protein interactions and gene expression changes using techniques like gene ontology analysis.
• Analyzed publicly available gene expression data (GEO) from clinical prostate cancer samples.
• Performed wound-healing and Matrigel invasion assays to assess cell motility and invasiveness.

Main Results:

• PHB overexpression induced G1/S-phase cell cycle arrest and repressed AR and E2F activity in prostate cancer cells.
• PHB knockdown (siRNA) increased tumor growth and metastasis in mouse xenografts, while PHB overexpression reduced cell migration, invasion, and attachment.
• Gene ontology analysis revealed PHB regulates cell cycle, WNT family members (WNT7B, WNT9A, WNT10B), and cell adhesion pathways.
• Clinical data showed decreased PHB expression and increased WNT expression in metastatic prostate cancer.
• Androgen signaling influenced WNT gene expression, but WNTs were also strongly regulated by the cell cycle, with PHB loss promoting WNT expression.

Conclusions:

• PHB acts as a critical suppressor of prostate cancer progression by inhibiting AR, E2F, and WNT signaling pathways.
• Loss of PHB function contributes to increased metastatic potential in prostate cancer, potentially through upregulation of WNT signaling and cell cycle dysregulation.
• The complex AR:PHB:E2F:WNT interaction axis represents a potential therapeutic target for managing prostate cancer metastasis.